Atara Biotherapeutics Inc... (ATRA)
NASDAQ: ATRA
· Real-Time Price · USD
8.08
0.06 (0.75%)
At close: Jun 26, 2025, 2:01 PM
0.75% (1D)
| Bid | 7.82 |
| Market Cap | 54.91M |
| Revenue (ttm) | 101.58M |
| Net Income (ttm) | -15.64M |
| EPS (ttm) | -2.26 |
| PE Ratio (ttm) | -3.58 |
| Forward PE | -6.02 |
| Analyst | Buy |
| Ask | 8.31 |
| Volume | 11,815 |
| Avg. Volume (20D) | 58,740 |
| Open | 8.06 |
| Previous Close | 8.02 |
| Day's Range | 8.00 - 8.09 |
| 52-Week Range | 5.00 - 18.70 |
| Beta | 0.18 |
About ATRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Atara Biotherapeutics Inc. is scheduled to release its earnings on Aug 11, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+15.13%
Atara Biotherapeutics shares are trading higher af...
Unlock content with
Pro Subscription
1 month ago
+5.79%
Atara Biotherapeutics shares are trading higher after the company provided updates on EBVALLO and announced the FDA has lifted its clinical hold to resume the clinical trials.
